About
Jay Goss is General Partner at Wavemaker Three-Sixty Health, the leading early-stage healthtech venture fund in the U.S. Since launching in 2018, Wavemaker 360 has invested in over 60 companies, focusing on Seed and Series A startups. The fund leverages a network of 400+ Limited Partners—primarily healthcare organizations and professionals—providing unique insights and advantages in deal sourcing, diligence, and scaling healthtech innovations. Healthcare investing is evolving faster than ever, driven by digital health, AI, and emerging care models. In this session, Jay Goss, seasoned healthtech investor and General Partner at Wavemaker 360, shares the current landscape of healthcare venture investing. Attendees will learn which sectors are attracting capital, the emerging trends shaping startup growth, and what investors look for in early-stage companies poised to transform healthcare. Jay Goss discusses where capital is flowing, how early-stage startups can position themselves for success, and the factors investors evaluate when funding healthcare innovations. Participants will gain practical insights to understand market dynamics, identify promising opportunities, and navigate the complexities of healthtech financing. Highlights 1. Discover the current trends and opportunities in healthcare investing. 2. Understand how early-stage healthtech startups secure Seed and Series A funding. 3. Learn from real-world examples of successful healthcare investments. 4. Gain insights into investor priorities and deal evaluation strategies. Learning Objectives 1. Explain the current state of healthcare venture investing. 2. Identify sectors and innovations attracting early-stage investment. 3. Understand the criteria investors use to evaluate healthtech startups. 4. Apply strategies to position startups for funding success. 5. Assess trends shaping the future of healthcare innovation and investment.
You can also join this program via the mobile app. Go to the app